7GP-51985-83505
7 vaccinations
4 coded responses
49 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 209 / MD
- Registered
- 2021-04-12
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Dose 1 — Pfizer-BioNTech
-
2021-04-12
Registered in v-safe
-
2021-04-12
Dose 2 — Pfizer-BioNTech
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-05-10
-
2021-05-17
Survey response — day 35, dose 2MedDRA: Hypersensitivity, Photophobia, Sneezing — Feeling: Good · Be unable to workFree text: Sneezing, eye sensitivity - allergiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-24
- 2021-07-12
- 2021-10-11
-
2021-10-16
Dose 3 — Pfizer-BioNTech
- 2021-10-18
- 2021-10-19
- 2021-10-20
- 2021-10-21
- 2021-10-22
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-11-13
- 2021-11-20
- 2021-11-27
- 2022-01-15
-
2022-03-12
Dose 4 — Pfizer-BioNTech
- 2022-04-18
-
2022-07-16
Dose 5 — Pfizer-BioNTech
-
2022-10-03
Dose 6 — Pfizer-BioNTech
-
2022-10-05
Survey response — days 1–6 daily, dose 6MedDRA: Abdominal pain, Medical procedure — Feeling: Good · Site: Pain · Abdominal pain · Be unable to work or attend schoolFree text: I had an endometrial biopsy today. The abdominal pain is related to this procedureMedDRA releases: 2024-11 · check-in free text available
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-10-31
- 2022-11-07
- 2022-11-14
- 2023-01-02
-
2023-04-03
Survey response — 6 months, dose 6MedDRA: Cough, Nasal congestion — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-04-03
Report sent to call center — 6 months, dose 6Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2023-04-04
Call successfulNot applicable - Accidental Reporting
-
2023-05-06
Dose 7 — Pfizer-BioNTech
- 2023-05-09
- 2023-05-10
- 2023-05-11
- 2023-05-12
- 2023-05-13
- 2023-05-20
- 2023-05-27
- 2023-06-03
- 2023-06-10
- 2023-06-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Pfizer-BioNTech | |
| 2 | 2021-04-12 | Pfizer-BioNTech | |
| 3 | 2021-10-16 | Pfizer-BioNTech | No |
| 4 | 2022-03-12 | Pfizer-BioNTech | No |
| 5 | 2022-07-16 | Pfizer-BioNTech | No |
| 6 | 2022-10-03 | Pfizer-BioNTech | No |
| 7 | 2023-05-06 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-04-03 | Successful 2023-04-04 |
Not applicable - Accidental Reporting |
Free text
Release 8 — day 35, dose 2
Symptoms: Sneezing, eye sensitivity - allergies
Release 12 — days 1–6 daily, dose 6
Systemic reaction (other): I had an endometrial biopsy today. The abdominal pain is related to this procedure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Photophobia | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
| SRO | Abdominal pain | · | · | ✓ |
| SRO | Medical procedure | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release